Literature DB >> 23653425

The ketogenic diet in Dravet syndrome.

Linda Laux1, Robyn Blackford.   

Abstract

Dravet syndrome is an infantile epilepsy syndrome with intractable pleomorphic seizures, cognitive impairment, and a number of comorbidities including ataxia/gait abnormalities and behavioral issues. Antiseizure medications are only partially effective in controlling seizures. Secondary to the intractable epilepsy, patients are often on multiple antiseizure medications with significant accumulative neurotoxic side effects. Specifically for Dravet syndrome, the medical literature includes both laboratory and clinical research that supports the use of the ketogenic diet. In addition, a review of the children with Dravet syndrome who were treated with the ketogenic diet at our center was undertaken. Thirteen of the 20 children (65%) with Dravet syndrome treated with the ketogenic diet experienced a greater than 50% reduction in seizure frequency. The ketogenic diet is a good alternative to medication for seizure management in children with Dravet syndrome.

Entities:  

Keywords:  Dravet; ketogenic diet; severe myoclonic epilepsy; severe myoclonic epilepsy in infancy; treatment

Mesh:

Year:  2013        PMID: 23653425     DOI: 10.1177/0883073813487599

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  14 in total

1.  Dravet in the dish: mechanisms of hyperexcitability.

Authors:  Detlev Boison
Journal:  Epilepsy Curr       Date:  2014-09       Impact factor: 7.500

2.  Stiripentol for dravet syndrome: is it worth it?

Authors:  Eric Kossoff
Journal:  Epilepsy Curr       Date:  2014-01       Impact factor: 7.500

Review 3.  Treatment Strategies for Dravet Syndrome.

Authors:  Kelly G Knupp; Elaine C Wirrell
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

Review 4.  Pharmacotherapy for Dravet Syndrome.

Authors:  Adam Wallace; Elaine Wirrell; Daniel L Kenney-Jung
Journal:  Paediatr Drugs       Date:  2016-06       Impact factor: 3.022

Review 5.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

6.  The Efficacy of Ketogenic Diet for Specific Genetic Mutation in Developmental and Epileptic Encephalopathy.

Authors:  Ara Ko; Da E Jung; Se H Kim; Hoon-Chul Kang; Joon S Lee; Seung T Lee; Jong R Choi; Heung D Kim
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

Review 7.  Ketogenic Diet and Epilepsy.

Authors:  Marzena Ułamek-Kozioł; Stanisław J Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Nutrients       Date:  2019-10-18       Impact factor: 5.717

8.  Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome.

Authors:  Marta Rubio; Sara Valdeolivas; Fabiana Piscitelli; Roberta Verde; Valentina Satta; Eva Barroso; Marisol Montolio; Luis Miguel Aras; Vincenzo Di Marzo; Onintza Sagredo; Javier Fernández-Ruiz
Journal:  Pharmacol Res Perspect       Date:  2016-03-05

9.  Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: A clinical prospective study.

Authors:  Qiong Wu; Hua Wang; Yu Ying Fan; Jun Mei Zhang; Xue Yan Liu; Xiu Ying Fang; Feng Hua Yang; Qing Jun Cao; Ying Qi
Journal:  Brain Behav       Date:  2018-04-18       Impact factor: 2.708

10.  Seizure control by decanoic acid through direct AMPA receptor inhibition.

Authors:  Pishan Chang; Katrin Augustin; Kim Boddum; Sophie Williams; Min Sun; John A Terschak; Jörg D Hardege; Philip E Chen; Matthew C Walker; Robin S B Williams
Journal:  Brain       Date:  2015-11-25       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.